NFKB1 and neoplasm: Biological targets of apigenin relevant to tumor potential are known to involve MAPK/NFkappaB, phospho-JAK1/ STAT3 signaling [17], VEGF, aromatase, proteasomal processes, fatty acid synthase [18–21] and the Fas-associated protein with death domain (FADD) [22].